Now showing items 1-4 of 4

  • Admission C – reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The 'Bergen stroke study' 

    Idicula, Titto T.; Brøgger, Jan C.; Næss, Halvor; Waje-Andreassen, Ulrike; Thomassen, Lars (BioMed Central, 2009-04-28)
    Background: There is growing evidence that inflammation plays an important role in atherogenesis. Previous studies show that C-reactive protein (CRP), an inflammatory marker, is associated with stroke outcomes and future ...
    Journal articlePeer reviewed
  • Association between visceral, cardiac and sensorimotor polyneuropathies in diabetes mellitus 

    Søfteland, Eirik; Brock, Christina; Frøkjær, Jens B.; Brøgger, Jan C.; Madácsy, László; Gilja, Odd Helge; Arendt-Nielsen, Lars; Simrén, Magnus; Drewes, Asbjørn M.; Dimcevski, Georg Gjorgji (Elsevier, 2014)
    Aims: Gastrointestinal complaints are common in diabetes mellitus. However, its association to peripheral sensorimotor and autonomic neuropathies is not well investigated. The aim was to assess skin, muscle, bone and ...
    Journal article
  • Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma 

    Svendsen, Agnete; Verhoeff, Joost J. C.; Immervoll, Heike; Brøgger, Jan C.; Kmiecik, Justyna; Poli, Aurélie; Netland, Inger A.; Planagumà, Jesús; Torsvik, Anja; Sakariassen, Per Øystein; Bjerkvig, Rolf; Enger, Per Øyvind; Tronstad, Karl Johan (Springer, 2011-08-24)
    Glioblastoma (GBM) is a highly aggressive brain tumour, where patients respond poorly to radiotherapy and exhibit dismal survival outcomes. The mechanisms of radioresistance are not completely understood. However, cancer ...
    Peer reviewedJournal article
  • Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study 

    Logallo, Nicola; Næss, Halvor; Idicula, Titto T.; Brøgger, Jan C.; Waje-Andreassen, Ulrike; Thomassen, Lars (BioMed Central, 2011-09-25)
    Background: A possible synergic role of serum uric acid (SUA) with thrombolytic therapies is controversial and needs further investigations. We therefore evaluated association of admission SUA with clinical improvement ...
    Peer reviewedJournal article